Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: Tom Bourbulas who wrote (1189)	6/7/1999 8:28:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 1870

I think you can thank Murphy and CTSL. He has stopped covering the stock based on his theory that his lousy performance over the past two years in biotech was because he was too enthusiastic about small cap, early stage companies. He advised his subscribers to exit the weekend after the big runup. I don't know if he sold near the high but his advice was too late for his subscribers. I think he probably sold out today following the news that they were moving company HQ to NE. For myself, I pay little attention to Murphy anymore although I still subscribe because I think I understand how his ego colors his judgement. I will hold the stock until there are definite results on its anticode research. That's why I bought to begin with and so far all the results have been positive. All just MHO.